Teplitsky Liane Rae
Teplitsky Liane Rae, COO, reported a transaction classified as grant at PULSE BIOSCIENCES, INC. involving 200000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 200000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 08, 2026
- Filing date
- Aug 28, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingPLSE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001437749-26-029231 Restricted Stock Units
- Transaction date
- Aug 08, 2026 Filed Aug 28, 2026, 11:45 PM · 20d delay
- Shares
- 200,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 200,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - delayed_filing-6 points
reporting_delay_days = 20
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Operating Officer
- F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
- F2
The RSUs will vest upon certain performance-based criteria established by the Board of Directors.
- F3
Two sevenths of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option…
0 other transactions
0 recent txs